Home/Pipeline/Peregrine System Renal Denervation

Peregrine System Renal Denervation

Hypertension

Phase 3Active

Key Facts

Indication

Hypertension

Phase

Phase 3

Status

Active

Company

Ablative Solutions

About Ablative Solutions

Ablative Solutions is pioneering a catheter-based renal denervation (RDN) system designed to treat patients with uncontrolled hypertension. Its Peregrine System Infusion Catheter utilizes a micro-infusion of dehydrated ethanol to precisely target the renal nerves, offering a potential alternative to lifelong medication. The company is currently conducting clinical trials to demonstrate the safety and efficacy of its approach. As a private entity, Ablative Solutions operates in the competitive but high-potential interventional cardiology and hypertension management market.

View full company profile

Therapeutic Areas

Cardiovascular Hypertension

Other Hypertension Drugs

Drug	Company	Phase	Status
Valsartan EP Impurity B	Synthink Research Chemicals	Reference Standard	Active
Norliqva® (Amlodipine Oral Solution)	CMP Pharma	Approved	Marketed
Renal & Hepatic Denervation for Hypertension	Metavention	Feasibility	Active
MVD-1 (SANA)	Eolo Pharma	Discovery	Active
Hypertension Program	Closed Loop Medicine	Development	Active
GMRx2	George Medicines	Phase 3	Active
High Blood Pressure Study	West Coast Research	Phase 3/4	Active
Biobeat Cuff‑less ABPM Patch	Biobeat	Commercial	Active
Zilebesiran (ALN-AGT)	Alnylam Pharmaceuticals	Phase 3	Active (KARDIA trials)
DehydraTECH-CBD	Lexaria Bioscience	Human Clinical	Active